[Drug-induced parkinsonism. Clinical aspects compared with Parkinson disease].
BACKGROUND
Drug-induced Parkinsonism (DIP) is the second commonest cause of Parkinson syndrome, after Parkinson disease (PD) and represents between 10% and 30% of all patients with Parkinsonism.


OBJECTIVE
To study the frequency and drugs responsible for DIP and to compare some of the clinical characteristics of these patients and those with PD.


METHODS
A retrospective community based study in Bajo Aragon district to determine the frequency of PD and other Parkinsonism, including DIP. PD was diagnosed on the criteria proposed by the United Kingdom Parkinson's Disease Society Brain Bank and DIP on the criteria of Jiménez et al.


RESULTS
Calcium antagonists were the cause of 73% of the DIP, followed by neuroleptic drugs (11.5%). There were 73% women (19/26). The patients with DIP were older than those with PD when their symptoms started (p = 0.02). In patients with DIP, 48% presented with bilateral symptoms as compared with 7% in PD (p < 0.0001).


CONCLUSIONS
1. Cinarizine is the main drug responsible for DIP (58%) 2. As compared with patients with PD, patients with DIP are mainly women, older, more frequently have bilateral onset of symptoms and consult the doctor sooner.
Servicio de Neurología, Hospital Comarcal de Barbastro, Huesca.
J M
JM
Errea-Abad
J R
JR
Ara-Callizo
C
C
Aibar-Remón
D000368:Aged; D002121:Calcium Channel Blockers / Q000009:adverse effects*; D002936:Cinnarizine / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000175:diagnosis*; D010302:Parkinson Disease, Secondary / Q000139:chemically induced* / Q000175:diagnosis*; D012189:Retrospective Studies
D002121:Calcium Channel Blockers; D002936:Cinnarizine